Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 239.67 USD -0.21% Market Closed
Market Cap: 20B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Laboratory Corporation of America Holdings
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Laboratory Corporation of America Holdings
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Laboratory Corporation of America Holdings
NYSE:LH
Net Issuance of Debt
$1B
CAGR 3-Years
N/A
CAGR 5-Years
41%
CAGR 10-Years
13%
DaVita Inc
NYSE:DVA
Net Issuance of Debt
$1.2B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chemed Corp
NYSE:CHE
Net Issuance of Debt
-$16.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Net Issuance of Debt
$2B
CAGR 3-Years
N/A
CAGR 5-Years
60%
CAGR 10-Years
16%
CVS Health Corp
NYSE:CVS
Net Issuance of Debt
$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
5%
Cigna Corp
NYSE:CI
Net Issuance of Debt
$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Market Cap
20.1B USD
Industry
Health Care

Laboratory Corporation of America Holdings, commonly referred to as LabCorp, has established itself as a leader in the biomedical testing and diagnostics industry. Founded in 1971, the company operates with a mission to improve health and improve lives by providing critical laboratory services to healthcare providers, pharmaceutical companies, and patients. LabCorp offers a comprehensive range of tests, encompassing everything from routine blood work to complex genomic testing. This diverse portfolio positions LabCorp to benefit from the growing demand for diagnostic services, particularly as healthcare continues to evolve toward precision medicine and personalized care. For investors, LabCorp's strategic initiatives and strong financial performance paint a compelling picture. The company has successfully expanded through a series of acquisitions, enhancing its capabilities and market reach. With a focus on innovation, LabCorp has invested heavily in advanced technologies and digital solutions to streamline operations and enhance customer experience. As the healthcare landscape shifts toward value-based care, LabCorp is well-positioned to capture market share and drive revenue growth. With a history of consistent earnings and a commitment to shareholder value, LabCorp represents a potentially attractive investment for those looking to engage in the evolving healthcare sector.

LH Intrinsic Value
259.89 USD
Undervaluation 8%
Intrinsic Value
Price

See Also

What is Laboratory Corporation of America Holdings's Net Issuance of Debt?
Net Issuance of Debt
1B USD

Based on the financial report for Sep 30, 2024, Laboratory Corporation of America Holdings's Net Issuance of Debt amounts to 1B USD.

What is Laboratory Corporation of America Holdings's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
13%

Over the last year, the Net Issuance of Debt growth was 1 028%.

Back to Top